Document is current
Any future updates will be listed below
-
Authors
Ishii, Ryotaro
Takizawa, Tsubasa
Suzuki, Shiho
Danno, Daisuke
Miura, Moemi
Tanizawa, Yoshinori
Osaga, Satoshi
Hashimoto, Chie
Komori, Mika
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 24 April 2025
First Online: 7 May 2025
Declarations
:
: The Medical Corporation TOUKEIKAI Kitamachi Clinic ethics committee approved this study (number BGQ09531) on April 19, 2023. This study was conducted per ethical principles originating from the Declaration of Helsinki and that was consistent with Good Pharmacoepidemiology Practices. All applicable Japanese laws and regulations were followed. All survey respondents provided electronic informed consent and agreed to participate in the study. All data were anonymized before analysis.
: Not applicable.
: RI received consulting fees from Amgen K.K., Eli Lilly Japan K.K., Daiichi Sankyo Co., Ltd., and Otsuka Pharmaceutical Co., Ltd; speaker honoraria from Amgen K.K., Daiichi Sankyo Co., Ltd., and Otsuka Pharmaceutical Co., Ltd. TT is a consultant/advisor and/or serves on an advisory board for Eli Lilly Japan K.K., Otsuka Pharmaceutical Co., Ltd., Amgen K.K., Pfizer Japan Inc., and Teijin Pharma Ltd. He received speaker honoraria from Eli Lilly Japan K.K., Daiichi Sankyo Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Amgen K.K., Kowa Company, Ltd., Kyowa Kirin Co., Ltd., Eisai Co., Ltd., UCB Japan Co., Ltd., Takeda Pharmaceutical Company Ltd., and Santen Pharmaceutical, a grant from Pfizer Japan Inc., and research funding from Eli Lilly Japan K.K. and Tsumura & Co., outside the submitted work. SS received speaker honoraria from Amgen K.K., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., and Otsuka Pharmaceutical Co., Ltd. DD serves on the advisory boards of and received speaker honoraria from Amgen K.K., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., and Otsuka Pharmaceutical Co., Ltd. MM is an employee of Social Survey Research Information Co., Ltd. Social Survey Research Information Co., Ltd. performed data collection and statistical analyses in this study and was sponsored by Eli Lilly Japan K.K. YT, SO, CH, and MK are employees of Eli Lilly Japan K.K. and may own stock/stock options of Eli Lilly and Company.
